NPIPA2
Nuclear pore complex-interacting protein family member A2
Also known as: NPIA2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- E9PIF3
- Gene
- NPIPA2
- Ensembl
- ENSG00000254852
- Chromosome
- 16
- Canonical length
- 369 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to be involved in mRNA transport and protein transport. Predicted to be located in nuclear membrane. Predicted to be part of nuclear pore. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>E9PIF3|NPIPA2
1 MVKLSIVLTP RFLSHDQGQL TKELQQHVKS VTCPCEYLRK VINTLADHRH RGTDFGGSPW
61 LLIITVFLRS YKFAISLCTS YLCVSFLKTI FPSQNGHDGS TDVQQRARRS NRRRQEGIKI
121 VLEDIFTLWR QVETKVRAKI CKMKVTTKVN RHDKINGKRK TAKEHLRKLS MKEREHGEKE
181 RQVSEAEENG KLDMKEIHTY MEMFQRAQAL RRRAEDYYRC KITPSARKPL CNRVRMAAAE
241 HRHSSGLPYW PYLTAETLKN RMGHQPPPPT QQHSIIDNSL SLKTPPECLL TPLPPSALPS
301 ADDNLKTPAE CLLYPLPPSA DDNLKTPPEC LLTPLPPSAP PSADDNLKTP PKCVCSLPFH
361 PQRMIISRNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPIPA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 22 nTPM
- testis: 14 nTPM
- pituitary gland: 8.9 nTPM
- colon: 8.4 nTPM
- blood vessel: 7.9 nTPM
- skeletal muscle: 6.6 nTPM
Single-cell type
- podocytes: 1 nCPM
- early spermatids: 0.7 nCPM
- late primary spermatocytes: 0.7 nCPM
- renal collecting duct intercalated cells: 0.5 nCPM
- distal convoluted tubule cells: 0.4 nCPM
- astrocytes: 0.3 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 8.5 nTPM
- cerebral cortex: 6.4 nTPM
- pons: 5.3 nTPM
- white matter: 5.3 nTPM
- medulla oblongata: 4.7 nTPM
- hippocampal formation: 4.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -0.02
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPIPA2 as an antibody target. Whether an autoantibody or antibody against NPIPA2 could matter depends on whether native NPIPA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPIPA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NPIPA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...